Modelling Microglial Innate Immune Memory In Vitro: Understanding the Role of Aerobic Glycolysis in Innate Immune Memory.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 May 2023
Historique:
received: 20 04 2023
revised: 09 05 2023
accepted: 16 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Microglia, the resident macrophages of the central nervous system, play important roles in maintaining brain homeostasis and facilitating the brain's innate immune responses. Following immune challenges microglia also retain immune memories, which can alter responses to secondary inflammatory challenges. Microglia have two main memory states, training and tolerance, which are associated with increased and attenuated expression of inflammatory cytokines, respectively. However, the mechanisms differentiating these two distinct states are not well understood. We investigated mechanisms underlying training versus tolerance memory paradigms in vitro in BV2 cells using B-cell-activating factor (BAFF) or bacterial lipopolysaccharide (LPS) as a priming stimulus followed by LPS as a second stimulus. BAFF followed by LPS showed enhanced responses indicative of priming, whereas LPS followed by LPS as the second stimulus caused reduced responses suggestive of tolerance. The main difference between the BAFF versus the LPS stimulus was the induction of aerobic glycolysis by LPS. Inhibiting aerobic glycolysis during the priming stimulus using sodium oxamate prevented the establishment of the tolerized memory state. In addition, tolerized microglia were unable to induce aerobic glycolysis upon LPS restimulus. Therefore, we conclude that aerobic glycolysis triggered by the first LPS stimulus was a critical step in the induction of innate immune tolerance.

Identifiants

pubmed: 37240311
pii: ijms24108967
doi: 10.3390/ijms24108967
pmc: PMC10219556
pii:
doi:

Substances chimiques

Lipopolysaccharides 0
Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : CRC-RS 950-232402
Pays : Canada
Organisme : CIHR
ID : FDN-148397
Pays : Canada

Références

Front Immunol. 2020 Sep 25;11:546415
pubmed: 33101271
Adv Neurobiol. 2014;11:13-30
pubmed: 25236722
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
Neurosci Biobehav Rev. 2021 Dec;131:1150-1168
pubmed: 34715148
Nat Commun. 2020 Mar 25;11(1):1559
pubmed: 32214088
Brain Behav Immun. 2017 Jul;63:99-107
pubmed: 27622677
J Neuroinflammation. 2022 May 14;19(1):111
pubmed: 35568856
Nat Rev Neurosci. 2003 Feb;4(2):103-12
pubmed: 12563281
Front Behav Neurosci. 2009 Aug 24;3:14
pubmed: 19738918
Exp Mol Med. 2016 Jul 15;48(7):e245
pubmed: 27416781
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
Cell Rep. 2022 Aug 2;40(5):111161
pubmed: 35926455
PLoS Comput Biol. 2012;8(5):e1002526
pubmed: 22615556
Antioxidants (Basel). 2021 Jan 14;10(1):
pubmed: 33466581
Cell Metab. 2019 Sep 3;30(3):493-507.e6
pubmed: 31257151
Front Cell Neurosci. 2022 Jun 03;16:908315
pubmed: 35722614
Sci Adv. 2022 Mar 4;8(9):eabi6672
pubmed: 35235358
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nature. 2022 Oct;610(7931):327-334
pubmed: 36171283
Transl Psychiatry. 2015 Apr 07;5:e543
pubmed: 25849982
Brain Behav Immun. 2021 Mar;93:66-79
pubmed: 33358979
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Am J Psychiatry. 2020 Jan 1;177(1):66-75
pubmed: 31581799
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
Nat Commun. 2018 Sep 25;9(1):3769
pubmed: 30254300
Behav Brain Res. 2006 Apr 25;169(1):39-47
pubmed: 16413067
Nature. 2018 Apr;556(7701):332-338
pubmed: 29643512
Arch Gen Psychiatry. 1988 Feb;45(2):189-92
pubmed: 3337616
Trends Neurosci. 2020 Nov;43(11):854-869
pubmed: 32958333
Front Cell Neurosci. 2020 Oct 15;14:558181
pubmed: 33192308
Brain Behav Immun. 2023 Jan;107:16-31
pubmed: 36174883
Front Immunol. 2021 May 12;12:639049
pubmed: 34054807
Nat Commun. 2021 May 21;12(1):3015
pubmed: 34021136
Cell Rep. 2022 Mar 29;38(13):110600
pubmed: 35354026
Glia. 2021 Mar;69(3):567-578
pubmed: 32946147
Cell Mol Life Sci. 2015 Dec;72(24):4867-84
pubmed: 26118661
Int J Mol Sci. 2021 Feb 17;22(4):
pubmed: 33671212
ALTEX. 2009;26(2):83-94
pubmed: 19565166
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Nat Rev Neurol. 2014 Nov;10(11):643-60
pubmed: 25311587
Cell Metab. 2016 Jul 12;24(1):158-66
pubmed: 27374498
Brain Sci. 2022 Aug 05;12(8):
pubmed: 36009104
Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):148-51
pubmed: 10026389
Transl Psychiatry. 2013 Mar 12;3:e240
pubmed: 23481627
Glia. 2018 Mar;66(3):505-521
pubmed: 29134693
Nat Immunol. 2016 Apr;17(4):406-13
pubmed: 26950237
Front Immunol. 2023 Mar 22;14:1052925
pubmed: 37033967
Front Behav Neurosci. 2022 Sep 12;16:989011
pubmed: 36172465
J Neuroinflammation. 2016 Jul 11;13(1):182
pubmed: 27400875
Physiol Rev. 2021 Jul 1;101(3):739-795
pubmed: 33270534
J Neurosci. 2011 Oct 26;31(43):15511-21
pubmed: 22031897
Nutr Rev. 2017 Dec 1;75(12):951-970
pubmed: 29186623
J Innate Immun. 2022;14(1):42-50
pubmed: 33378755
Trends Immunol. 2019 Apr;40(4):358-374
pubmed: 30833177
Cell Rep. 2017 Jul 25;20(4):779-784
pubmed: 28746864
Front Neurosci. 2017 Feb 02;11:43
pubmed: 28210209
Nature. 2018 Jul;559(7712):114-119
pubmed: 29950719
Neuron. 2021 Aug 18;109(16):2573-2589.e9
pubmed: 34233151
Front Immunol. 2020 Mar 20;11:493
pubmed: 32265936
J Neuroinflammation. 2021 Jun 9;18(1):129
pubmed: 34107997
Trends Immunol. 2018 Jun;39(6):438-445
pubmed: 29716792
Brain Behav Immun. 2020 Oct;89:20-31
pubmed: 32454135
J Autism Dev Disord. 2015 Dec;45(12):4015-25
pubmed: 24366406
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):857-62
pubmed: 12810767
Neurology. 2000 Oct 24;55(8):1158-66
pubmed: 11071494
Front Aging Neurosci. 2020 Aug 13;12:256
pubmed: 32922284
Neuropsychopharmacology. 2022 Sep;47(10):1755-1763
pubmed: 35835992
Brain Behav Immun. 2017 Jul;63:88-98
pubmed: 27697456
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Front Immunol. 2021 Jan 20;11:625630
pubmed: 33552090
Neurobiol Dis. 2017 Oct;106:291-300
pubmed: 28751257
J Autism Dev Disord. 2010 Dec;40(12):1423-30
pubmed: 20414802

Auteurs

Morgan Towriss (M)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Brian MacVicar (B)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Annie Vogel Ciernia (AV)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Articles similaires

Animals Natural Killer T-Cells Mice Adipose Tissue Lipid Metabolism
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH